Article
How long does gene therapy last? 4-year follow-up of phase 3 voretigene neparvovec trial in RPE65-associated LCA/inherited retinal disease
2019-08-01
Abstract excerpt
No abstract is available from the source.
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4a7c8474-441b-5166-8a8a-a714af226e3f
- DOI
- 10.1016/j.jaapos.2019.08.018
